Scientific advisory board

Our scientific advisory board aims to implement strategies and policies that maximise and sustain research performance, research income, and quality of infrastructure at MCCIR and to keep in touch with current research activities and the needs of industry and academia.

It also aims to enhance communications and mutually beneficial collaborations between the Faculty of Biology, Medicine and Health at Manchester and industry.

The board also works to improve access to facilities and funding opportunities, as well as develop graduate and postgraduate employment opportunities.

Board members

• Professor Michael Dustin (Kennedy Institute of Rheumatology, University of Oxford and Skirball Institute of Biomolecular Medicine, New York University School of Medicine)
• Professor Sir Marc Feldmann (Kennedy Institute of Rheumatology, University of Oxford)
• Professor David Wraith (School of Cellular and Molecular Medicine, University of Bristol)